Last edition
News about "Bayer Noria Therapeutics and PSMA Therapeutics"
Bayer enters agreement to buy Noria Therapeutics and PSMA Therapeutics
Bayer announced that it has entered into an agreement to acquire Noria Therapeutics (Noria) and PSMA Therapeutics. Through this acquisition, Bayer will obtain exclusive rights to a differentiated alpha radionuclide investigational compound based on actinium-225 and a small molecule directed towards prostate-specific membrane antigen (PSMA)
Bayer Noria Therapeutics And PSMA Therapeutics | 06/06/2021 | By Darshana | 198
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy